QuantiFERON-TB Gold Plus (IGRA)

The Florida Department of Health (FDOH), Palm Beach County Laboratory has a need to purchase reagents and supplies to perform Mycobacterium tuberculosis specific antigen testing using the QuantiFERON-TB Gold Plus, an Interferon Gamma Release Assay (IGRA). The FDOH, Palm Beach County Laboratory requires specialized reagents and collection devices for the automated quantitative measurement of Interferon gamma (IFN-g) for Cell mediated immune response to infection with Mycobacterium tuberculosis performed on instrumentation currently owned by the FDOH, Palm Beach County Laboratory. This testing is critical to the clients served in Palm Beach to identify those that have been infected with Mycobacterium tuberculosis and is also used for testing outreaches conducted by the County Health Department's Tuberculosis Program to identify possible clusters of tuberculosis outbreaks within the county. The FDOH in Palm Beach County requests authorization to purchase, as a single source, test kits and collection devices from Qiagen, LLC for a 3-year term. The estimated dollar amount for this single source acquisition is $300,000. Qiagen, LLC is the sole manufacturer and distributor of FDA approved reagents and collection devices for the QuantiFERON-TB Gold Plus In-Tube (IGRA) system and testing products.

This opportunity is restricted to Qiagen, LLC as the sole manufacturer and distributor of the required reagents and collection devices compatible with the FDOH's existing testing instrumentation. The FDOH has determined that maintaining continuity with these specialized products is in the best interest of the state. There are no set-aside designations or restrictions on the types of organizations that can respond. The contract term is for 3 years with an estimated value of $300,000.